These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34303789)

  • 61. How do Uremic Toxins Affect the Endothelium?
    Cunha RSD; Santos AF; Barreto FC; Stinghen AEM
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32575762
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Uremic Toxins and Their Relation with Oxidative Stress Induced in Patients with CKD.
    Pieniazek A; Bernasinska-Slomczewska J; Gwozdzinski L
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201270
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Indoxyl Sulfate, a Uremic Endotheliotoxin.
    Lano G; Burtey S; Sallée M
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260489
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of lipids and uremic toxins in cardiovascular disease in CKD.
    Massy ZA
    Clin Exp Nephrol; 2014 Apr; 18(2):255-6. PubMed ID: 24072415
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Distal Colon Motor Dysfunction in Mice with Chronic Kidney Disease: Putative Role of Uremic Toxins.
    Hoibian E; Florens N; Koppe L; Vidal H; Soulage CO
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772737
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
    Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
    Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
    Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
    Niwa T
    Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Understanding and Therapeutic Strategies of Chinese Medicine on Gut-Derived Uremic Toxins in Chronic Kidney Disease.
    Guo C; Rao XR
    Chin J Integr Med; 2018 Jun; 24(6):403-405. PubMed ID: 29752692
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction.
    Cunha RSD; Azevedo CAB; Falconi CA; Ruiz FF; Liabeuf S; Carneiro-Ramos MS; Stinghen AEM
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324674
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Uremic Toxins and Blood Purification: A Review of Current Evidence and Future Perspectives.
    Magnani S; Atti M
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33808345
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ablation of dihydroceramide desaturase 1, a therapeutic target for the treatment of metabolic diseases, simultaneously stimulates anabolic and catabolic signaling.
    Siddique MM; Li Y; Wang L; Ching J; Mal M; Ilkayeva O; Wu YJ; Bay BH; Summers SA
    Mol Cell Biol; 2013 Jun; 33(11):2353-69. PubMed ID: 23547262
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity.
    Rodriguez-Cuenca S; Barbarroja N; Vidal-Puig A
    Biochim Biophys Acta; 2015 Jan; 1851(1):40-50. PubMed ID: 25283058
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Gut Microbiota and Cardiovascular Uremic Toxicities.
    Velasquez MT; Centron P; Barrows I; Dwivedi R; Raj DS
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29997362
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Truncated domains of human serum albumin improves the binding efficiency of uremic toxins: A surface plasmon resonance and computational approach.
    Nerusu A; Vaikuntapu PR; Chinthapalli DK; Podile AR; Subramanyam R
    Int J Biol Macromol; 2020 Jul; 155():1216-1225. PubMed ID: 31734369
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Accumulated uremic toxins attenuate bone mechanical properties in rats with chronic kidney disease.
    Iwasaki Y; Kazama JJ; Yamato H; Shimoda H; Fukagawa M
    Bone; 2013 Dec; 57(2):477-83. PubMed ID: 23920356
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A rapid and sensitive method for simultaneous determination of eight protein-bound uremic toxins in human serum by UHPLC-MS/MS: application in assessing peritoneal dialysis.
    Wang Z; Jiang H; Chen X; Song X; Xu F; Chen F; Mao Z; Gao S; Chen W
    J Pharm Biomed Anal; 2020 Jul; 186():113312. PubMed ID: 32361090
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adsorption capacity of poly(ether imide) microparticles to uremic toxins.
    Tetali SD; Jankowski V; Luetzow K; Kratz K; Lendlein A; Jankowski J
    Clin Hemorheol Microcirc; 2016; 61(4):657-65. PubMed ID: 26639769
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
    Fujii H; Nakai K; Fukagawa M
    Ther Apher Dial; 2011 Apr; 15(2):125-8. PubMed ID: 21426501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.